N@N

DiagnoCure announces second quarter 2010 results

^{Published on 2010-06-09 13:40:51 - Market Wire}
 

 Financial Data ------------------------------------------------------------------------- For the second quarter ended April 30 ------------------------------------------------------------------------- 2010 2009 ------------------------------------------------------------------------- $ $ ------------------------------------------------------------------------- Sales 16,846 30,564 ------------------------------------------------------------------------- Revenue under research and license agreement 286,055 312,685 ------------------------------------------------------------------------- Interest 41,192 123,903 ------------------------------------------------------------------------- Total revenues 344,093 467,152 ------------------------------------------------------------------------- Cost of sales 12,076 16,422 ------------------------------------------------------------------------- Gross margin 332,017 450,730 ------------------------------------------------------------------------- Operating expenses (before stock-based compensation) 2,420,316 2,941,385 ------------------------------------------------------------------------- Net loss (before stock-based compensation) (2,088,299) (2,490,655) ------------------------------------------------------------------------- Stock-based compensation 116,533 160,091 ------------------------------------------------------------------------- Net loss before income taxes (2,204,832) (2,650,746) ------------------------------------------------------------------------- Future income taxes - 28,509 ------------------------------------------------------------------------- Net loss (2,204,832) (2,622,237) ------------------------------------------------------------------------- Basic and diluted loss per share (0.05) (0.06) ------------------------------------------------------------------------- Weighted average number of common shares outstanding 42,965,148 42,799,475 ------------------------------------------------------------------------- Consolidated Balance Sheets ------------------------------------------------------------------------- As at April 30 ------------------------------------------------------------------------- 2010 2009 ------------------------------------------------------------------------- Cash, cash equivalents, temporary and long-term investments 9,682,540 14,083,829 ------------------------------------------------------------------------- Total assets 20,295,730 27,781,898 ------------------------------------------------------------------------- Shareholders' equity 17,426,433 23,224,245 -------------------------------------------------------------------------